X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/08/06/2925018/0/en/aTyr-Pharma-Announces-Appointment-of-Jayant-Aphale-PhD-as-Vice-President-of-Technical-Operations.html
https://www.globenewswire.com/news-release/2024/07/30/2920954/0/en/aTyr-Pharma-Announces-Research-Study-with-Stanford-Medicine.html
https://www.globenewswire.com/news-release/2024/07/22/2916494/0/en/aTyr-Pharma-Completes-Enrollment-in-Global-Pivotal-Phase-3-EFZO-FIT-Study-of-Efzofitimod-in-Pulmonary-Sarcoidosis.html
https://www.globenewswire.com/news-release/2024/06/03/2892167/0/en/aTyr-Pharma-Announces-Nasdaq-Stock-Ticker-Symbol-Change-from-LIFE-to-ATYR.html
https://www.globenewswire.com/news-release/2024/05/24/2888158/0/en/aTyr-Pharma-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com/news-release/2024/05/15/2882256/0/en/aTyr-Pharma-to-Present-Poster-Describing-Efzofitimod-s-Mechanism-of-Action-at-the-American-Thoracic-Society-2024-International-Conference.html
https://www.globenewswire.com/news-release/2024/05/14/2881310/0/en/aTyr-Pharma-Announces-Second-Positive-DSMB-Review-for-Efzofitimod-in-Phase-3-EFZO-FIT-Study-in-Pulmonary-Sarcoidosis.html
https://www.globenewswire.com/news-release/2024/05/06/2875757/0/en/aTyr-Pharma-to-Present-at-Upcoming-Investor-Conferences.html
https://www.globenewswire.com/news-release/2024/05/02/2874631/0/en/aTyr-Pharma-Announces-First-Quarter-2024-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2024/04/01/2855130/0/en/aTyr-Pharma-to-Participate-in-April-Investor-Conferences.html
Market Place
Share 
